Actinogen Medical Ltd
F:3AC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Actinogen Medical Ltd
F:3AC
|
AU |
|
E
|
EUROKAI GmbH & Co KgaA
XMUN:EUK3
|
DE |
|
Kelso Technologies Inc
F:LB4A
|
CA |
|
Acerinox SA
F:ACE
|
ES |
|
IperionX Limited
ASX:IPX
|
AU |
|
F
|
Firan Technology Group Corp
F:22F
|
CA |
Shareholder Yield
Current shareholder yield for 
3AC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
3AC Price
Actinogen Medical Ltd
| Average Annual Return | 4.76% |
| Standard Deviation of Annual Returns | 65.9% |
| Max Drawdown | -94% |
| Market Capitalization | 204.4m EUR |
| Shares Outstanding | 2 711 640 064 |
| Percentage of Shares Shorted |
N/A
|
3AC Return Decomposition
Main factors of price return
Stock Splits
3AC's latest stock split occurred on Dec 3, 2013
The company executed a 1-for-2 stock split, meaning that for every 2 shares held, investors received 1 new share.
Before the split, 3AC traded at 0.005 per share. Afterward, the share price was about 0.008.
The adjusted shares began trading on Dec 3, 2013. This was the only stock split in 3AC's history.